BRD4 and hepatocellular carcinoma: In addition, HCC patients with higher BRD4 expression had lower survival rates than patients with lower BRD4 expression (log-rank test, hazard ratio [HR] = 2.18, 95% confidence interval [CI] = 1.32 to 3.6, p < 0.001; Figure 1D).